Morse Asset Management, Inc
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1705711
DARIEN, CT
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,228,579
+$510,884 QoQ
Shares Held
10,526
-0.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#468
of 1,735 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Morse Asset Management, Inc holds $10,205,191 across 7 Biotechnology names. VRTX ranks #1 (51.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
10,526 | $5,228,579 | |
| 2 | ASND |
Ascendis Pharma A/S
|
9,589 | $2,557,578 | |
| 3 | ARGX |
Argenx SE
|
1,348 | $1,250,633 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
67,649 | $566,222 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
1,378 | $392,688 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
334 | $208,262 | |
| 7 | MANE |
Veradermics, Inc
|
10 | $1,229 |
All Filings in VRTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,228,579 | 10,526 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,717,695 | 10,565 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,725,371 | 10,423 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $4,035,850 | 10,305 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,579,772 | 10,287 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $5,071,702 | 10,461 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $4,250,498 | 10,555 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,640,103 | 9,977 | Shares | Sole | 2024-11-20 | |
| 2024-06-30 | $4,741,102 | 10,115 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,261,611 | 10,195 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,860,979 | 9,489 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $2,761,751 | 7,942 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,576,333 | 7,321 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,857,652 | 5,896 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,505,987 | 5,215 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,139,918 | 3,937 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $516,239 | 1,832 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $380,233 | 1,457 | Shares | Sole | 2022-05-12 | |
| 2020-12-31 | $299,679 | 1,268 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,987,333 | 10,978 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,487,085 | 8,567 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $887,553 | 3,730 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||